Related Experiment Video

Updated: Sep 5, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Brefeldin A inhibits osteoclastic bone resorption through induction of apoptosis

S Niwa1, O Ishibashi, T Inui

  • 1Takarazuka Research Institute, Novartis Pharma K. K, Japan.

Life Sciences
|May 15, 2002
PubMed

Insights

Brefeldin A (BFA) inhibits osteoclastic bone resorption by inducing apoptosis in osteoclasts. This fungal metabolite reduces pit formation and cell viability, acting through a p53-dependent mechanism.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Brefeldin A (BFA) is a fungal metabolite with a macrocyclic lactone structure.
  • Its known biological activity includes inhibiting intracellular protein transport.
  • BFA has been explored for cancer treatment.

Purpose of the Study:

  • To investigate the effect of BFA on osteoclastic pit formation in vitro.
  • To determine the mechanism by which BFA affects osteoclast function and viability.

Main Methods:

  • Osteoclastic pit formation assays.
  • Cell viability assays.
  • Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay.
  • DNA ladder formation assay.
  • Western blot analysis for p53 protein accumulation.

Main Results:

  • BFA reduced osteoclastic pit formation in a concentration-dependent manner (IC50: 11.3-13.3 nM).
  • BFA decreased osteoclast cell viability (IC50: 13.9 nM).
  • BFA induced DNA fragmentation and apoptosis in osteoclasts, with p53 nuclear accumulation observed.

Conclusions:

  • BFA inhibits osteoclastic bone resorption.
  • The inhibition is mediated by the induction of apoptosis in osteoclasts.
  • This apoptotic process involves a p53-dependent mechanism.

More Related Videos

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...